Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials

SIMPLE SUMMARY: Treatment strategies in advanced, metastatic small cell lung cancer have been recently implemented by the combination of chemotherapy and immunotherapy. Nevertheless, the magnitude of survival benefit observed in clinical trials does not reproduce the major improvements observed in n...

Descripción completa

Detalles Bibliográficos
Autores principales: Facchinetti, Francesco, Di Maio, Massimo, Tiseo, Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565587/
https://www.ncbi.nlm.nih.gov/pubmed/32947924
http://dx.doi.org/10.3390/cancers12092645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565587/
https://www.ncbi.nlm.nih.gov/pubmed/32947924
http://dx.doi.org/10.3390/cancers12092645

Ejemplares similares